Legal Analysis - Scrip Regulatory Affairs

14 October 2011

Everyday counts: why pharmaceutical companies in the EU need to make sure they get the right SPC term

Pharmaceutical companies using the centralised authorisation procedure in the EU may be entitled to a slightly longer supplementary certificate procedure term than they might think, says Mike Snodin.

This article appeared in the October issue of Scrip Regulatory Affairs

Back to all news